Literature DB >> 16206735

The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients. Report of five cases and review of the literature.

Daniel R Fassett1, James Pingree, John R W Kestle.   

Abstract

Myxopapillary ependymomas (MPEs) have historically been thought to be benign tumors occurring most frequently in adults. Only 8 to 20% of these tumors occur in the first two decades of life, making this tumor a rarity in pediatric neurosurgery. Five patients with intraspinal MPEs were treated by the authors between 1992 and 2003. Four (80%) of these five patients suffered from disseminated disease of the central nervous system (CNS) at the time of presentation; this incidence is much higher than that reported in the combined adult and pediatric literature. Combining five pediatric case series reported in the literature with the present series, the authors review a total of 26 cases of pediatric patients with intraspinal MPEs. In nine cases (35%) CNS metastases occurred. In those cases in which patients underwent screening for CNS tumor dissemination, however, the incidence of disseminated disease was 58% (seven of 12 patients). In pediatric patients MPEs may spread throughout the CNS via cerebrospinal fluid pathways; therefore, MR imaging of the entire CNS axis is recommended at both presentation and follow-up review to detect tumor dissemination.

Entities:  

Mesh:

Year:  2005        PMID: 16206735     DOI: 10.3171/ped.2005.102.1.0059

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  34 in total

Review 1.  Neurocytoma: a comprehensive review.

Authors:  Mehar Chand Sharma; Prabal Deb; Suash Sharma; Chitra Sarkar
Journal:  Neurosurg Rev       Date:  2006-08-29       Impact factor: 3.042

Review 2.  Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.

Authors:  John Glod; Gilbert J Rahme; Harpreet Kaur; Eric H Raabe; Eugene I Hwang; Mark A Israel
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

3.  Extraspinal sacrococcygeal ependymoma masquerading as sacrococcygeal teratoma in the pediatric patient.

Authors:  Ruchi Amin; Elizabeth Berdan; Jeffrey Knipstein; Jason Jarzembowski; Sabina Siddiqui
Journal:  Pediatr Surg Int       Date:  2017-11-14       Impact factor: 1.827

4.  PET findings of intramedullary tumors of the spinal cord using [18F] FDG and [11C] methionine.

Authors:  N Tomura; Y Ito; H Matsuoka; T Saginoya; S-I Numazawa; Y Mizuno; K Watanabe
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-28       Impact factor: 3.825

5.  Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes.

Authors:  James E Bates; Gyujae Choi; Michael T Milano
Journal:  J Neurooncol       Date:  2016-06-15       Impact factor: 4.130

6.  Spinal myxopapillary ependymoma with interval drop metastasis presenting as cauda equina syndrome: case report and review of literature.

Authors:  Shrikant V Rege; Sharadendu Narayan; Harshad Patil; Abhishek Songara
Journal:  J Spine Surg       Date:  2016-09

Review 7.  Classification and controversies in pathology of ependymomas.

Authors:  Catherine Godfraind
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

Review 8.  Spinal cord ependymomas in children and adolescents.

Authors:  Martin Benesch; Didier Frappaz; Maura Massimino
Journal:  Childs Nerv Syst       Date:  2012-09-08       Impact factor: 1.475

9.  Long term outcomes following surgical resection of myxopapillary ependymomas.

Authors:  Carlos A Bagley; Sean Wilson; Karl F Kothbauer; Markus J Bookland; Fred Epstein; George I Jallo
Journal:  Neurosurg Rev       Date:  2009-02-17       Impact factor: 3.042

10.  Unique molecular characteristics of pediatric myxopapillary ependymoma.

Authors:  Valerie N Barton; Andrew M Donson; Bette K Kleinschmidt-DeMasters; Diane K Birks; Michael H Handler; Nicholas K Foreman
Journal:  Brain Pathol       Date:  2009-09-10       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.